Session highlights
-
Overview of perioperative immunotherapies and the surgeon’s role in adoptive cellular therapies.
-
Timely updates on the latest clinical advances in the field, including data from recent scientific meetings and clinical trials.
-
Dedicated opportunities for clinicians to ask questions and receive direction on difficult cases.
-
Practical education in caring for patients receiving immunotherapy in combination with surgery.
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.